C4 Therapeutics, Inc. (CCCC)

CIK 1662579 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for C4 Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001628280-26-070575
Nov 5, 20268-K0001628280-26-070560
Oct 2, 202640001470831-26-000924
Oct 2, 202640001470831-26-000925
Sep 25, 20268-K0001628280-26-063497
Sep 21, 202640001470831-26-000895
Aug 14, 20261440001950047-26-008193
Aug 14, 2026SCHEDULE 13G/A0002050709-26-000022
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000920
Aug 14, 20261440001950047-26-008190
Aug 14, 2026SCHEDULE 13G/A0000902664-26-003524
Aug 13, 20261440001950047-26-008065
Aug 12, 2026SCHEDULE 13G/A0000895421-26-000231
Aug 12, 20261440001950047-26-008039
Aug 11, 202610-Q0001628280-26-055494
Aug 11, 20268-K0001628280-26-055490
Jul 27, 2026SCHEDULE 13G0002012383-26-002217
Jul 13, 202640001470831-26-000705
Jul 2, 202640001470831-26-000689
Jul 2, 202640001470831-26-000688
Jun 26, 202640001470831-26-000667
Jun 26, 202640001470831-26-000665
Jun 26, 202640001470831-26-000673
Jun 26, 202640001470831-26-000670
Jun 26, 202640001470831-26-000659